Preliminary Scientific Programme

 

24 May 2012

  Hall Blue Hall Green (9) Hall Green (8)
09.00–11.00 Satellite Symposium Satellite Symposium
Abbott
Russian Antihypertensive
League Meeting
11.00–11.30 break
11.30–13.00 Satellite Symposium
MSD
Satellite Symposium
Boehringer Ingelheim
Working group
13.00–14.00 break
14.00–16.00 Satellite Symposium Satellite Symposium
Servier
NICA study
Investigator Meeting
16.00–17.00 break
17.00–18.00

Opening Ceremony (Hall Blue)

Evgeny Shlyakhto (Russia): Welcoming of the participants. Hypertension burden in Russian Federation.
Alberto Zanchetti (Italy): Resistance to blood pressure lowering benefits: how far can cardiovascular risk be lowered by treatment in high risk patients?

19.00–20.00 Welcome cocktail

 

25 May 2012

  Hall Blue Hall Green (8)
09.00–11.00 Oral Session
«Pathophysiological and clinical aspects of resistant hypertension»
Oral Session
«Obstructive sleep apnea and resistant hypertension»
11.00–11.30 coffee break
11.30–13.30

Plenary Session (Hall Blue)
«Basic aspects of resistant hypertension»

1. Anna Dominiczak (Scotland, UK): Genomics and other “omics” as new tools in clinical hypertension
2. Edward G. Lakatta (USA): Can we intervene in the epidemic of predominately systolic hypertension in Western society?
3. Peter Nilsson (Sweden): A life course approach on cardiovascular risk. Gene-environmental influences.
4. Stephane Laurent (France): Large artery damage as a key factor of resistant hypertension

13.30–14.30 lunch
14.30–16.30

Plenary Session (Hall Blue)
«Novel technologies and clinical approaches in resistant hypertension»

1. Murray Esler (Australia): Endovascular renal denervation of the kidneys: A neuro­science cure for essential hypertension?
2. Roland Schmieder (Germany): Renal denervation program
3. Krzysztof Narkiewicz (Poland): OSA and resistant hypertension
4. Gianfranco Parati (Italy): Carotid baroreceptor stimulation as a non-pharmacologic treatment for resistant hypertension
5. Margus Viigimaa (Estonia): Combination therapy in treatment of resistant hypertension

16.30–17.00 coffee break
17.00–18.30 Oral session
«Arterial stiffness and central blood pressure»
Master class
«Renal denervation: clinical and technical aspects»
  Gala Dinner in Petrodvorets

 

26 May 2012

  Hall Blue Hall Green (8)
09.00–11.00

Plenary session (Hall Blue)
«Unresolved issues of resistant hypertension»

1. Joseph I. Shapiro (USA): Is the interventional treatment of renal artery stenosis justified?
2. Frans Leenen (Canada): CNS effects of circulating and local aldosterone in hypertension
3. Elena Baranova (Russia): Management of resistant hypertension in postmenopausal women
4. Alexei Bagrov (USA): Cardiotonic steroids and salt-sensitivity

11.00–11.30 coffee break
11.30–13.30

Plenary session (Hall Blue)
«Clinical aspects of resistant hypertension»

1. Lars Lindholm (Sweden): Uncontrolled hypertension – can we do better?
2. Janna Kobalava (Russia): Patient’s compliance and resistant hypertension
3. Alexandra Konradi (Russia): Physician’s inertia in hypertension treatment – a significant barrier for blood pressure control
4. Olle Melander (Sweden): Pathophysiological links between hypertension, diabetes and cardiovascular disease
5. Andrzej Januszewicz (Poland): Principal findings of the Polish Resistant Hypertension [RESIST-POL] Registry – implications for clinical practice

13.30–14.30 break
14.30–16.30 Satellite Symposium Satellite Symposium
16.30–17.00 break
17.00–18.30 Satellite Symposium Satellite Symposium